Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP803851.RAvu4N3OvilRm-BMepcibVQuD2FtCwsjw-b6giM_aeXSs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP803851.RAvu4N3OvilRm-BMepcibVQuD2FtCwsjw-b6giM_aeXSs130_assertion type Assertion NP803851.RAvu4N3OvilRm-BMepcibVQuD2FtCwsjw-b6giM_aeXSs130_head.
- NP803851.RAvu4N3OvilRm-BMepcibVQuD2FtCwsjw-b6giM_aeXSs130_assertion description "[These data provide new insights into TRAIL-induced necroptosis with PARP-1 being active effector downstream of RIPK1/RIPK3 initiators and suggest that pharmacological inhibitors of RIPKs and PARP-1 could be new treatment options for immune-mediated hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803851.RAvu4N3OvilRm-BMepcibVQuD2FtCwsjw-b6giM_aeXSs130_provenance.
- NP803851.RAvu4N3OvilRm-BMepcibVQuD2FtCwsjw-b6giM_aeXSs130_assertion evidence source_evidence_literature NP803851.RAvu4N3OvilRm-BMepcibVQuD2FtCwsjw-b6giM_aeXSs130_provenance.
- NP803851.RAvu4N3OvilRm-BMepcibVQuD2FtCwsjw-b6giM_aeXSs130_assertion SIO_000772 22814620 NP803851.RAvu4N3OvilRm-BMepcibVQuD2FtCwsjw-b6giM_aeXSs130_provenance.
- NP803851.RAvu4N3OvilRm-BMepcibVQuD2FtCwsjw-b6giM_aeXSs130_assertion wasDerivedFrom befree-20150227 NP803851.RAvu4N3OvilRm-BMepcibVQuD2FtCwsjw-b6giM_aeXSs130_provenance.
- NP803851.RAvu4N3OvilRm-BMepcibVQuD2FtCwsjw-b6giM_aeXSs130_assertion wasGeneratedBy ECO_0000203 NP803851.RAvu4N3OvilRm-BMepcibVQuD2FtCwsjw-b6giM_aeXSs130_provenance.